Case Study

TranSenda International LLC has been acquired by BioClinica

TranSenda International LLC, a provider of clinical trial management software (CTMS) solutions, has been sold to BioClinica, a global provider of clinical trial management services, for an undisclosed consideration.

This acquisition is strategic in improving efficiencies for BioClinica's customers by reducing study duration and costs through integrated operational management.

Oaklins' team in Seattle initiated the transaction, assisted in the negotiations and acted as financial advisor to the seller in this transaction.

Tombstone image for TranSenda International LLC has been acquired by BioClinica

KEY DEAL CONTACTS

Scott Hardman

United States

Managing Director

VIEW PROFILE